Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?

Saudi J Gastroenterol. 2017 Sep-Oct;23(5):265-267. doi: 10.4103/sjg.SJG_292_17.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Amoxicillin / administration & dosage*
  • Amoxicillin / pharmacology
  • Drug Therapy, Combination
  • Female
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects
  • Humans
  • Hydrogen-Ion Concentration
  • Male
  • Omeprazole / administration & dosage
  • Omeprazole / pharmacology
  • Proton Pump Inhibitors / administration & dosage*
  • Proton Pump Inhibitors / pharmacology
  • Pyrroles / administration & dosage
  • Pyrroles / pharmacology
  • Stomach / chemistry
  • Sulfonamides / administration & dosage
  • Sulfonamides / pharmacology
  • Treatment Failure

Substances

  • 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
  • Proton Pump Inhibitors
  • Pyrroles
  • Sulfonamides
  • Amoxicillin
  • Omeprazole